Search for: "Grant v. Bristol-Myers Squibb"
Results 101 - 120
of 157
Sort by Relevance
|
Sort by Date
19 Mar 2012, 4:16 am
Judge Birss QC assures us that his decision in Merck Sharp Dohme Corp & Anor v Teva Pharma BV & Anor [2012] EWHC 627 (Pat), relating to an application by Bristol-Myers Squibb for an interim injunction pending trial, raises no issue of principle, but he does provide an enlightening discussion of how to address some issues of fact that are common in an application for a quia timet injunction, including a review of the European case law. [read post]
3 Mar 2012, 5:36 pm
Bristol-Myers Squibb, 97 F. [read post]
28 Oct 2011, 7:00 am
Arizona Gebhardt v. [read post]
30 Aug 2011, 2:00 am
US 6,475,521entitled BIPHASIC CONTROLLED RELEASE DELIVERY SYSTEM FOR HIGH SOLUBILITY PHARMACEUTICALS AND METHOD and owned by Bristol-Myers Squibb Co. [read post]
30 Aug 2011, 2:00 am
US 6,475,521entitled BIPHASIC CONTROLLED RELEASE DELIVERY SYSTEM FOR HIGH SOLUBILITY PHARMACEUTICALS AND METHOD and owned by Bristol-Myers Squibb Co. [read post]
25 Aug 2011, 7:01 am
Id. at 17-18.Finally, plaintiff was granted leave to amend (negligence only) in Salvio, slip op. at 18-19. [read post]
2 Jun 2011, 12:46 pm
Squibb & Sons, Inc. v. [read post]
26 Mar 2011, 5:00 pm
Bristol-Myers Squibb Co. v. [read post]
24 Mar 2011, 1:12 pm
Bristol-Myers Squibb, Inc., the employees claim that BMS paid kickbacks to physicians and pharmacists to increase prescriptions and dispensing of the company’s drugs. [read post]
18 Mar 2011, 10:04 am
Bristol-Myers Squibb, 97 F. [read post]
18 Feb 2011, 11:47 am
The defendants in both sets of actions were Sanofi Aventis and Sanofi-Synthelabo, Inc., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
16 Feb 2011, 12:04 am
It looks like they would also do away with all the problems of the “threshold” requirement introduced by Phillips v Mirabella (the nature of the problem is laid out at paragraphs 19 to 27 of Bristol-Myers Squibb v Faulding). [read post]
16 Dec 2010, 1:54 pm
See Sidari v. [read post]
10 Dec 2010, 3:06 am
Inc., 2000 US Dist LEXIS 21316, *12-13 [2000]; Grant v Bristol-Myers Squibb, 97 F Supp 2d 986, 992 [2000]). [read post]
24 Nov 2010, 12:37 am
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an act of… [read post]
17 Nov 2010, 1:48 am
(Patents Post Grant Blog) US: University inventions, Stanford vs Roche (IPEG) US: What ultimately matters in deciding the ‘gene patenting’ issue? [read post]
9 Nov 2010, 3:09 pm
The patent also was granted a pediatric exclusivity period and will expire in February 2014. [read post]
4 Nov 2010, 6:14 am
”); Bristol-Myers Squibb Co. v. [read post]
2 Nov 2010, 1:40 am
When reviewing the grant of a preliminary injunction, this court "views the matter in light of the burdens and presumptions that will inhere at trial. [read post]
28 Sep 2010, 3:14 pm
Par Pharmaceutical Companies, Inc. et al (Patent Docs) Baraclude (Entecavir) – US: Patent infringement complaint filed following Paragraph IV certification: Bristol-Myers Squibb Co. v. [read post]
